
Davos 2023
Why and how we must accelerate AI’s impact on global health
AI could revolutionize drug discovery and healthcare, but AI’s impact on global health depends on representative data, trustworthy design and scalability.
Pratap was elected CEO of ZS in July 2021. ZS is a 11,500-strong global healthcare consultancy. Prior to this, he led the firm’s global Pharmaceuticals practice for 9 years and founded and led its Advanced Data Science capability which focuses on AI. He has also served on ZS’s board since 2012, and on the Board of Virtua Health System since 2015. He holds a PhD in AI from UC Berkeley.
AI could revolutionize drug discovery and healthcare, but AI’s impact on global health depends on representative data, trustworthy design and scalability.
Already, AI in healthcare solutions have proven more efficient and have become more effective and the challenge remains in scaling up these technologies.